North America and Western Europe are expected to remain the leading regional markets for aortic stent grafts over the next decade. That is the conclusion of a study by Future Market Insights (FMI), which looks ahead from 2017 until 2027.
FMI put the global market at about US$1,705.3 Mn at the end of 2017. By the end of 2027, it expects the market to reach US$2,694.1 Mn. That works out to a compound annual growth rate of 4.2% by value.
North America is the largest region, and FMI calls it the most lucrative, with a market attractiveness index of 2.0. Its market is projected to reach US$1,184.7 Mn by the end of 2027. Western Europe ranks second, since it is set to bring in US$676.0 Mn by the same point.
By product, abdominal aortic stent grafts hold the biggest share. The segment was worth an estimated US$1,549.5 Mn in 2017, after it had also led the market in 2016. FMI expects that lead to hold until 2027.
Hospitals are the largest group of end users. As a result, their segment is forecast to reach US$2,039.4 Mn by 2027, growing at 4.3% a year.
The report, titled Aortic Stents Grafts Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027, also profiles the main companies by market share and strategy. They include Cook Medical, W.L. Gore and Associates, Medtronic plc, Terumo Corporation and MicroPort Scientific Corporation. Endologix, Bolton Medical, Cardinal Health, C. R. Bard, JOTEC GmbH and Lombard Medical are also covered.
